CYP — Cynata Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$4.02m
- AU$3.12m
- AU$0.08m
Brief: Cynata Therapeutics Seeks Trading Halt
Brief: Cynata Therapeutics Posts HY Revenue And Other Income Of A$1.8 Million
Brief: Lumc To Fund New Clinical Trial Of Cynata's Cymerus Mscs In Kidney Transplantation
Australia's Cynata Therapeutics rises on grant for heart diseases drug study
Brief: FDA Clears IND For Cynata's Phase 2 Clinical Trial Of CYP-001 in GvHD
Cynata Therapeutics jumps most in nearly 8 months on U.S. FDA clearance
Brief: Cynata Therapeutics Says US FDA Clears Ind For Co's Phase 2 Clinical Trial Of Cyp-001 In Gvhd
Australia Stock Exchange release from CYNATA THERAPEUT : Updated Investor Presentation
Australia Stock Exchange release from CYNATA THERAPEUT : PRE_NR Ends: 09:41:31
Australia Stock Exchange release from CYNATA THERAPEUT : Notice of Allowance for Cynata Chinese Patent
Brief: Cynata Therapeutics Posts HY Loss Attributable Of A$1.1 Million
Australia Stock Exchange release from CYNATA THERAPEUT : PRE_NR Ends: 15:10:13
Australia Stock Exchange release from CYNATA THERAPEUT : Appendix 4D & Half-Year Financial Statements
Australia Stock Exchange release from CYNATA THERAPEUT : Quarterly Activity Report & Appendix 4C
Australia Stock Exchange release from CYNATA THERAPEUT : PRE_NR Ends: 15:26:55
Australia Stock Exchange release from CYNATA THERAPEUT : Cynata Receives Decision to Grant a Patent in Japan
Australia Stock Exchange release from CYNATA THERAPEUT : PRE_NR Ends: 09:36:20
Australia Stock Exchange release from CYNATA THERAPEUT : Cynata Receives $832,677 R&D Tax Incentive Refund
Australia's Cynata Therapeutics jumps on Fujifilm deal